Contents

Search


casanthranol

Will be discontinued 06/02. Safety data not provided to FDA. Indications: relief of constipation

General

laxative

References

  1. Prescriber's Letter 9(6):32 2002

Component-of

casanthranol/docusate (Peri-Colace) casanthranol/sodium docusate